Cargando…

Alpha Synuclein only Forms Fibrils In Vitro when Larger than its Critical Size of 70 Monomers

The aggregation of α‐synuclein into small soluble aggregates and then fibrils is important in the development and spreading of aggregates through the brain in Parkinson's disease. Fibrillar aggregates can grow by monomer addition and then break into fragments that could spread into neighboring...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez, Santiago Enrique, Whiten, Daniel R., Meisl, Georg, Ruggeri, Francesco Simone, Hidari, Eric, Klenerman, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518629/
https://www.ncbi.nlm.nih.gov/pubmed/34383993
http://dx.doi.org/10.1002/cbic.202100285
_version_ 1784584268715917312
author Sanchez, Santiago Enrique
Whiten, Daniel R.
Meisl, Georg
Ruggeri, Francesco Simone
Hidari, Eric
Klenerman, David
author_facet Sanchez, Santiago Enrique
Whiten, Daniel R.
Meisl, Georg
Ruggeri, Francesco Simone
Hidari, Eric
Klenerman, David
author_sort Sanchez, Santiago Enrique
collection PubMed
description The aggregation of α‐synuclein into small soluble aggregates and then fibrils is important in the development and spreading of aggregates through the brain in Parkinson's disease. Fibrillar aggregates can grow by monomer addition and then break into fragments that could spread into neighboring cells. The rate constants for fibril elongation and fragmentation have been measured but it is not known how large an aggregate needs to be before fibril formation is thermodynamically favorable. This critical size is an important parameter controlling at what stage in an aggregation reaction fibrils can form and replicate. We determined this value to be approximately 70 monomers using super‐resolution and atomic force microscopy imaging of individual α‐synuclein aggregates formed in solution over long time periods. This represents the minimum size for a stable α‐synuclein fibril and we hypothesis the formation of aggregates of this size in a cell represents a tipping point at which rapid replication occurs.
format Online
Article
Text
id pubmed-8518629
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85186292021-10-21 Alpha Synuclein only Forms Fibrils In Vitro when Larger than its Critical Size of 70 Monomers Sanchez, Santiago Enrique Whiten, Daniel R. Meisl, Georg Ruggeri, Francesco Simone Hidari, Eric Klenerman, David Chembiochem Full Papers The aggregation of α‐synuclein into small soluble aggregates and then fibrils is important in the development and spreading of aggregates through the brain in Parkinson's disease. Fibrillar aggregates can grow by monomer addition and then break into fragments that could spread into neighboring cells. The rate constants for fibril elongation and fragmentation have been measured but it is not known how large an aggregate needs to be before fibril formation is thermodynamically favorable. This critical size is an important parameter controlling at what stage in an aggregation reaction fibrils can form and replicate. We determined this value to be approximately 70 monomers using super‐resolution and atomic force microscopy imaging of individual α‐synuclein aggregates formed in solution over long time periods. This represents the minimum size for a stable α‐synuclein fibril and we hypothesis the formation of aggregates of this size in a cell represents a tipping point at which rapid replication occurs. John Wiley and Sons Inc. 2021-08-24 2021-10-01 /pmc/articles/PMC8518629/ /pubmed/34383993 http://dx.doi.org/10.1002/cbic.202100285 Text en © 2021 The Authors. ChemBioChem published by Wiley-VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Full Papers
Sanchez, Santiago Enrique
Whiten, Daniel R.
Meisl, Georg
Ruggeri, Francesco Simone
Hidari, Eric
Klenerman, David
Alpha Synuclein only Forms Fibrils In Vitro when Larger than its Critical Size of 70 Monomers
title Alpha Synuclein only Forms Fibrils In Vitro when Larger than its Critical Size of 70 Monomers
title_full Alpha Synuclein only Forms Fibrils In Vitro when Larger than its Critical Size of 70 Monomers
title_fullStr Alpha Synuclein only Forms Fibrils In Vitro when Larger than its Critical Size of 70 Monomers
title_full_unstemmed Alpha Synuclein only Forms Fibrils In Vitro when Larger than its Critical Size of 70 Monomers
title_short Alpha Synuclein only Forms Fibrils In Vitro when Larger than its Critical Size of 70 Monomers
title_sort alpha synuclein only forms fibrils in vitro when larger than its critical size of 70 monomers
topic Full Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518629/
https://www.ncbi.nlm.nih.gov/pubmed/34383993
http://dx.doi.org/10.1002/cbic.202100285
work_keys_str_mv AT sanchezsantiagoenrique alphasynucleinonlyformsfibrilsinvitrowhenlargerthanitscriticalsizeof70monomers
AT whitendanielr alphasynucleinonlyformsfibrilsinvitrowhenlargerthanitscriticalsizeof70monomers
AT meislgeorg alphasynucleinonlyformsfibrilsinvitrowhenlargerthanitscriticalsizeof70monomers
AT ruggerifrancescosimone alphasynucleinonlyformsfibrilsinvitrowhenlargerthanitscriticalsizeof70monomers
AT hidarieric alphasynucleinonlyformsfibrilsinvitrowhenlargerthanitscriticalsizeof70monomers
AT klenermandavid alphasynucleinonlyformsfibrilsinvitrowhenlargerthanitscriticalsizeof70monomers